Auris Medical Holding AG (EARS.OQ)
1.42USD
18 Apr 2018
-- (--)
$1.42
--
--
--
--
35,542
$9.70
$1.24
About
Overall
Beta: | -- |
Market Cap(Mil.): | $32.28 |
Shares Outstanding(Mil.): | 34.33 |
Dividend: | -- |
Yield (%): | -- |
Financials
BRIEF-Auris Medical Announces Early Repayment Of Part Of Its Loan Facility
* AURIS MEDICAL ANNOUNCES EARLY REPAYMENT OF PART OF ITS LOAN FACILITY
BRIEF-Thomas Meyer Reports 12.6 Pct Stake In Auris Medical As Of March 29
* THOMAS MEYER REPORTS 12.6 PCT STAKE IN AURIS MEDICAL HOLDING AG AS OF MARCH 29, 2018 - SEC FILING Source text: (https://bit.ly/2uJaqwA) Further company coverage:
BRIEF-Auris Regains Compliance With Nasdaq's Minimum Bid Price Requirement
* AURIS REGAINS COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE REQUIREMENT Source text for Eikon: Further company coverage:
BRIEF-Auris Medical Q4 Loss Per Share CHF 0.10
* AURIS MEDICAL PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
BRIEF-Auris Medical Holding AG - Shareholders Approved Merger Between Co And Auris Medical Newco - SEC Filing
* AURIS MEDICAL HOLDING AG - ON MARCH 12, AT THE GENERAL MEETING, SHAREHOLDERS APPROVED MERGER BETWEEN CO AND AURIS MEDICAL NEWCO - SEC FILING
BRIEF-Auris Medical Provides Business Update
* AURIS MEDICAL HOLDING AG - PRELIMINARY TOP-LINE DATA FROM TACTT3 TRIAL INDICATE THAT STUDY DID NOT MEET ITS PRIMARY EFFICACY ENDPOINT
BRIEF-Auris Medical Holding AG Files For Resale Of Up To 7.5 Mln Common Shares Issuable Upon Exercise Of Certain Outstanding Warrants
* AURIS MEDICAL HOLDING AG FILES FOR RESALE OF UP TO 7.5 MILLION COMMON SHARES ISSUABLE UPON EXERCISE OF CERTAIN OUTSTANDING WARRANTS - SEC FILING Source text: [http://bit.ly/2BPfTod] Further company coverage:
BRIEF-Auris Medical Reports New Data Highlighting Superior Bioavailability Of AM-125
* AURIS MEDICAL REPORTS NEW DATA HIGHLIGHTING SUPERIOR BIOAVAILABILITY OF AM-125 COMPARED TO ORAL BETAHISTINE
BRIEF-Auris Medical Announces Pricing Of $5.5 Mln Registered Direct Offering
* AURIS MEDICAL ANNOUNCES PRICING OF $5.5 MILLION REGISTERED DIRECT OFFERING
BRIEF-Auris Medical Announces Further Results From Healos Phase 3 Trial
* AURIS MEDICAL HOLDING AG SAYS ANNOUNCED FURTHER CLINICAL RESULTS FROM THE HEALOS PHASE 3 CLINICAL TRIAL, PROVIDES UPDATE ON AM-111 DEVELOPMENT PROGRAM